Retrophin

Biotechnology ResearchCalifornia, United States51-200 Employees

Retrophin is a biotechnology research company focused on identifying, developing and delivering therapies for people with rare diseases. Its portfolio includes four approved medicines for hepatology and nephrology, and it maintains a late-stage development program featuring sparsentan for FSGS and IgAN, while exploring potential treatments for NGLY1 deficiency and Alagille syndrome in collaboration with patient advocacy groups and government researchers. The company is based in San Diego, California, and emphasizes a patient-centered culture guided by values such as accountability, integrity and scientific excellence.

Its work targets rare kidney and liver disorders, serving patients and the healthcare community affected by these conditions and seeking to advance outcomes when few options exist. Through its approved products and a focused pipeline, Retrophin positions itself as a specialty biopharmaceutical company aiming to be globally integrated within the rare-disease field.

Sign up for free to view info

Email Format Employee directory